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A B S T R A C T
For over ten years, metallic skeletal endoprostheses have been produced in select cases by additive manu-
facturing (AM) and increasing awareness is driving demand for wider access to the technology. This review
brings together key stakeholder perspectives on the translation of AM research; clinical application, ongoing
research in the ﬁeld of powder bed fusion, and the current regulatory framework. The current clinical use of AM
is assessed, both on a mass-manufactured scale and bespoke application for patient speciﬁc implants. To illu-
minate the beneﬁts to clinicians, a case study on the provision of custom cranioplasty is provided based on
prosthetist testimony. Current progress in research is discussed, with immediate gains to be made through in-
creased design freedom described at both meso- and macro-scale, as well as long-term goals in alloy develop-
ment including bioactive materials. In all cases, focus is given to speciﬁc clinical challenges such as stress
shielding and osseointegration. Outstanding challenges in industrialisation of AM are openly raised, with pos-
sible solutions assessed. Finally, overarching context is given with a review of the regulatory framework involved
in translating AM implants, with particular emphasis placed on customisation within an orthopaedic remit. A
viable future for AM of metal implants is presented, and it is suggested that continuing collaboration between all
stakeholders will enable acceleration of the translation process.
1. Introduction
Implantation of metal endoprostheses are increasingly frequent
surgical procedures, with hip and knee arthroplasty accounting for over
117,000 surgical procedures in the UK annually. More broadly, skeletal
surgeries are the primary procedure for nearly one tenth of all hospital
admissions in England [1–3], and around 2 million hip replacements
were performed across the Organisation for Economic Co-operation and
Development (OECD) in 2015, a 30% increase since 2000 [4]. As po-
pulations within OECD nations continue to age [5] and obesity drives a
need for implants in increasingly younger cases, demand for implants is
projected to continue rising over the coming decades, with estimates
exceeding a 27% increase in total hip replacements by the 2030s [6–8].
Although the complication rate of such procedures is low, there remain
signiﬁcant clinical challenges, which may increase as age and obesity
related comorbidities become more prevalent [9,10]. Risk of infection
initiated at implant surfaces, managing osseointegration, and the in-
herent mechanical incompatibility of most alloys with bone, represent
three of the core clinical issues faced. Alongside the initial debilitation
of a patient from these complications, implant revision is typically more
costly than the primary procedure and further increases the risk of in-
fection or surgical complications [11–13].
Currently, the majority of skeletal endoprostheses are produced
from titanium (Ti) or cobalt chromium (CoCr) based alloys, which meet
the criteria of durability, strength, corrosion resistance and a low im-
mune response [14,15]. These characteristics however come at the cost
of the high stiﬀness of these alloys in comparison to bone. Mismatch
between the mechanical properties of bone and orthopaedic materials
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often causes ‘stress shielding’ in load-bearing implants, where regions of
native bone are exposed to reduced compressive or tensile stresses due
to the higher stiﬀness of the implant [16]. This can lead to a reduction
in bone density as ﬁrst formalised by Wolﬀ’s law, where bone under
reduced stress remodels, in turn causing aseptic loosening of implants
resulting in requirement for revision. For load bearing implants, max-
imising osseointegration to minimise risk of aseptic loosening is a key
focus [17], given that around 20% of orthopaedic revisions within two
years are associated with loosening [18]. Osteoblast adhesion is im-
proved by a roughened texture, though the optimum length-scale for
this texture remains a matter of some debate [19]. Conversely, for
temporary implants or those where removal may be necessary for
imaging, such as cranioplasty plates, clinicians may wish to actively
minimise osseointegration to reduce trauma to surrounding bone tissue
during explantation.
How best to control or inﬂuence cell adhesion to an implant is key
not only for managing osseointegration. Doing so whilst minimising
bacterial adhesion, remains one of the key challenges in modern or-
thopaedics [20–22]. Implant associated infections, often referred to as
periprosthetic infections (PPI), account for around 22 % of revision
surgeries in orthopaedics [1], and case series have reported infection in
up to 30 % of craniomaxillofacial revisions [23]. Such infections are
particularly diﬃcult to treat due to formation of bacterial bioﬁlms on
implant surfaces [24]. Bioﬁlms reduce the eﬃcacy of conventional
antibiotic prophylaxis through a range of mechanisms, including the
polysaccharide matrix of the ﬁlm itself, and increased coordination of
bacterial populations [25].
Typically, metallic implants have been manufactured by formative
techniques such as forging or casting, and subtractive methods for ex-
ample milling or machining. However, the past decade has seen in-
creasing interest in using additive manufacturing (AM) techniques, and
their potential to enable novel implant geometries or properties to
tackle the clinical challenges faced. AM technologies produce parts
from 3D data, by joining of raw materials in a layer-by-layer process
[26]. In the ﬁeld of metal implant manufacture, the most relevant
techniques are based upon powder bed fusion (PBF) methods, the basic
principles of which are shown in (Fig. 1). In PBF, layers of powder are
thermally fused by an energy source, such as a laser (L-PBF) or electron
beam (EB-PBF). A subsequent layer of powder is spread across the
surface and the next cross section of a part fused with the underlying
cross section, with this process repeated sequentially until completion.
Underlying powder layers provide a degree of support to material
above, although supporting structures may be required to stabilise parts
during manufacture. Other metal AM methods are available, most no-
tably direct energy deposition (DED) techniques, but the clinical
exploration of these methods for biomedical manufacture has been
more limited, possibly due to the lower resolution of DED and more
widespread commercialisation of PBF. As such, this review focusses on
the use of PBF given its current greater clinical relevance.
Unlike traditional powder metallurgy processes such as sintering,
PBF and DED produce geometrically complex parts with densities ex-
ceeding 99.5% without additional post-processing [27]. In practise,
careful process control is required to avoid remnant porosity or defects.
With extremely high localised cooling rates, metal AM processes have
unique microstructural characteristics. The melt pool in laser PBF, for
example, is typically of the order of 200 μm and cools at a rate of over
104 Ks−1 [28]. This generates very ﬁne microstructures that are stiﬀer
and have higher yield strength than equivalent cast or wrought mate-
rials [29].
As a novel manufacturing technique, PBF oﬀers opportunities in
enabling new design methodologies and material properties, but also
faces challenges in proving it can deliver suﬃcient clinical beneﬁts to
warrant wider adoption. This review seeks to give perspectives on four
areas;
1 The current impact of additive manufacturing on clinical practice
2 Opportunities for future clinical advances being made in a research
setting
3 Current challenges faced to further industrialisation of AM for en-
doprostheses
4 Regulatory challenges to widespread adoption of AM implants
Where relevant, advances made outside of biomedical research are
discussed in the context of future translation. In doing so, the intention
is to provide insight to both research focussed clinicians and researchers
in biomedical AM on current clinical practise in metal AM, and the
progress being made to translate research.
2. Clinical impact
In order to better describe the eﬀects of AM on clinical practice, the
regulatory division between mass manufactured and patient speciﬁc
implants can be used to broadly divide the market for endoprostheses.
Whilst the dental ﬁeld has shown rapid uptake of AM, adoption in
skeletal ﬁelds remains nascent, in part due to the regulatory burdens
faced. This assessment of clinical impact therefore focusses on non-
dental skeletal applications, as advances in dental AM are summarised
by Oliveira et al [30].Though current use of AM for mass manufactured
orthopaedic implants is limited, key examples of additional function-
ality gained and potential economic arguments for adoption are
Fig. 1. Schematic showing the principles of
powder bed fusion (PBF) additive manu-
facturing. a) Typical physical layout of PBF
apparatus. Dosed powder is spread across a
substrate and a cross section is thermally fused
by a directed energy source. The build plate
subsequently lowers, another layer of powder
is spread, and is fused to the material below. b)
Cross section of the build region. Unfused
powder provides a degree of support to over-
hanging material, or support structures can be
fused as appropriate.
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considered. As yet, long-term outcomes for such implants are not
available and cannot be discussed in depth.
2.1. Mass manufactured implants
The predominant use of AM from a mass manufacturing perspective
has been for its osseointegrative properties, with a number of products
featuring porous surfaces for long-term ﬁxation (Table 1). The relative
dominance of Ti-6Al-4 V over Co-Cr-Mo may be because focus has
primarily been on non-articulating surfaces, where the higher stiﬀness
of CoCr outweighs its better wear resistance [31]. This is compounded
by the move away from metal-on-metal hip surfaces, where CoCr was
particularly favoured. In particular, Ti acetabular cups have been a
favoured application of AM, with the ﬁrst approved designs implanted
in 2007, and ﬁve-year follow up showing a Kaplan-Meier survival es-
timate of 99.3% [32]. Spinal interbody fusion implants have also seen
widespread adoption across multiple manufacturers, including large
companies such as Stryker. Alongside possible osseointegration,
roughened surfaces enable friction between the implant and bone for
initial stability before bone ingrowth in cementless ﬁxation [33].
Roughened surfaces for ﬁxation can be produced with traditional
manufacturing methods, such as use of cast beads on the reverse of
acetabular cups and spray coating of ﬁxation surfaces [34]. However,
the increased design ﬂexibility of AM allows localised tailoring of the
mechanical and osseointegration properties within a single process, for
example by the use of solid and porous features. The application of
porosity has also been argued as advantageous for decreasing radio-
graphic signature [35,36].
Given that similar porous surfaces can be produced without the use
of AM and therefore a lack of any clear step-change in the clinical
function, it is key to consider economic justiﬁcations for use. From a
long-term perspective, AM may improve industrial sustainability both
in reducing material wastage, and allowing iterative product redesign
without the expense of retooling [38]. Though eﬃciency in material
usage by the recycling of powder feedstocks may motivate adoption
[39], investment in robust quality control is required to reduce risks
associated with reuse. Cost savings may be further oﬀset by the inﬂated
initial cost of powder, given the low yield of many powder production
methods within the crucial 15–105 μm size range [40,41]. Further,
arguments regarding iterative product redesign may be less valid in the
context of orthopaedic implant manufacture, as in practise any redesign
of an implant could necessitate resubmission to regulatory bodies. The
highly speciﬁc nature of orthopaedic implant regulation counters the
conventional wisdom that AM will be disruptive in providing custo-
misation on-demand for mass-manufactured products [42]. To do so
would require a signiﬁcant shift in the distinction between standardised
and patient speciﬁc implants, which as discussed in Section 5 is a key
cornerstone of existing regulatory frameworks.
Alternative arguments for adoption consider eﬀects in disrupting
conventional manufacturing supply chains, reducing lead time. The
signiﬁcance of this for mass manufactured implants remains to be es-
tablished, particularly when taking into account that the post proces-
sing of AM products can be more complex than for conventional
manufacturing. Speciﬁc to implant manufacture, the promise of dis-
tributed manufacture may allow new cost models for implant supply,
particularly where hospitals partner directly with manufacturers [43],
though the regulation of multiple manufacturing sites and their supply
chains may prove a barrier to this.
In summary, whilst AM has seen adoption for mass manufacture of
implants and mid-term outcomes are currently positive [32], data for
long-term outcomes are needed to demonstrate additional clinical
beneﬁt. Current adoption is likely being driven by a range of economic
factors, and consideration of possible future beneﬁts and the risk of
falling behind the adoption curve of new technologies. The adoption of
AM in dental implant manufacture may represent a model of industrial
uptake, with initial pioneering work performed in the late 1990s fol-
lowed by a broader recognition of the advantages in the ﬂexibility of
manufacture and wider uptake [44,45].
2.2. Patient speciﬁc implants
Commonly referred to as ‘custom’ implants, patient-matched or
patient speciﬁc implants (PSIs) are deﬁned as those designed and pro-
duced for use in a speciﬁc individual. From a regulatory perspective,
there are two key approaches to such implants: those that ﬁt a broad
‘envelope’ of design features whilst allowing greater ﬂexibility in the
size or shape of speciﬁc design elements than mass manufactured im-
plants, and those that are uniquely ‘custom’ and produced for atypical
clinical needs where it would be infeasible for a design envelope to exist
[46,47].
Examples of envelope type implants include cranioplasty plates and
typical craniomaxillofacial (CMF) applications, where a suﬃciently
large market has been developed to sustain small scale manufacture,
but where ﬁxed size or modular implants are inappropriate.
Table 1
Key examples of commercially mass-manufactured implants produced by AM that have been approved by the FDA [37].
Anatomical Region Product Type Alloys In Use Key Features and Clinical Beneﬁts Manufacturers FDA Number
Foot & Ankle Osteotomy truss Ti-6Al-4V Porous surface for osseointegration, reduced density for limited
radiographic artefacts
4-Web Medical Inc. K130185
Additive Orthopaedics K170214
Hip Acetabular cup Ti-6Al-4V Porous surface for ﬁxation and osseointegration Lima Corporation K141395
Smith & Nephew K150790
Femoral stem Theken K161184
Adler Ortho K171768
Knee Tibial cavity reinforcement Ti-6Al-4V Porous surface for ﬁxation and osseointegration Medacta International K170149
Tibial baseplate Stryker K123486
Sacroiliac Sacroiliac fusion Ti-6Al-4V Porous surface for ﬁxation and osseointegration SI-Bone Inc K162733
Spinal Interbody fusion Ti-6Al-4V Porous surface for ﬁxation and osseointegration Camber Spine Tech. K172446
Co-Cr-Mo Medicrea Int. S.A K163595
4-Web Medical Inc. K142112
K2M K163364
EIT K172888
Stryker K171496
Nexxt Spine LLC K171140
NuVasive K172676
joimax GmbH K151143
HT Medical K170318
CoreLink, LLC K162496
Renovis K170888
M. Lowther, et al. Additive Manufacturing 28 (2019) 565–584
567
Cranioplasty plate manufacture is presented as case a study in Section
2.3 to demonstrate how AM has altered the workﬂow of implant design
and manufacture in a clinical setting. From an economic perspective,
estimation of the market share for additive manufactured PSIs is diﬃ-
cult, with much more limited data collection for cranioplasties in
comparison to orthopaedic joint registries [48,49]. Currently across
Europe, several hospitals and implant manufacturers have reported
their use of AM for custom prostheses, but exact details of the extent of
this uptake remain unknown [50–52]. Positive uptake has also been
observed within the dental industry, particularly for the manufacture of
CoCr dental crowns and bridges [45].
For uniquely customised implants beyond speciﬁc CMF re-
constructions, AM implants have seen particular use in treatment of
bone tumours, such as giant cell tumours or sarcomas, which severely
aﬀect anatomy for which no existing modular implants are available.
Patient speciﬁc clavicle, scapula, and pelvic implants have all been
demonstrated (Fig. 2) and resulted in patients showing optimal Mus-
culoskeletal Tumor Society 93 (MSTS93) scores over a three year
follow-up period [53]. Positive results have also been achieved for
anatomical regions where existing implants limit joint function or
where large volumes of bone have been resected, aﬀecting stability,
such as irregularly shaped massive tibial defects [54]. A series of four
proximal tibia blocks demonstrated the advantages of AM over con-
ventional techniques, allowing use in conjunction with a standard knee
prosthesis whilst including a porous surface structure where ligaments
can be directly sutured [38].
Across all anatomical sites, the overarching process of designing AM
implants is heavily digitised, transferring patient scan data from MRI or
CT to design software, allowing direct replication of patient anatomy.
One current approach is based on the mirroring of healthy anatomy to
replace a defect, restoring symmetry that has been lost through trauma
or resection [52,54]. This process also has advantages in surgical
planning, with the ability to produce low-cost 3D printed polymer
models of the implantation site from the same scan data, which can in
turn be used to plan surgical management [55].
2.3. Case study: AM cranioplasty
Conventional patient-speciﬁc cranioplasty plates are cut from tita-
nium sheet and pressed onto a model of the defect region. This pre-
forming model is typically manufactured manually using patient CT
data. A physical model of the defect region is produced by 3D printing
in a polymer, and the defect manually recontoured by moulding of
clays. From this, a dental stone pre-form is made onto which the tita-
nium sheet can be pressed and moulded. Use of custom plates manu-
factured in this way has shown favourable outcomes in comparison to
allografts, autografts, or alternative alloplasty materials including those
shaped during surgery such as titanium mesh or
polymethylmethacrylate [23,56].
Typically, a period of at least 3 months is kept between craniectomy
and cranioplasty, though this waiting period may be up to 2 years
where patients are not yet neurologically stable [23,57]. However,
duration of pre-operative complications between the onset of a cranial
defect and the cranial plate insertion is a signiﬁcant complaint amongst
patients [58], and there remains conﬂicting evidence of whether
shortening the period between craniotomy and plate cranioplasty ne-
gatively aﬀects patient outcome; systematic review of literature by
Tasiou et al found that later cranioplasty may minimise surgical com-
plications, but early cranioplasty indicated improvement in key post-
operative indicators and reduced overall hospital stay duration
[59–63]. Though rapid manufacturing using AM could in principle re-
duce this waiting period, given the current practice in delaying cra-
nioplasty, this has not yet been the case. Rather than shortening the
total waiting period, AM has had a high impact minimising time at the
later clinical stage post-craniotomy, once a patient’s condition is suﬃ-
ciently stable to consider cranioplasty. As traditional cranioplasty
manufacturing takes up to 4 weeks, plates are typically ordered, man-
ufactured, and sterilised prior to scheduling of surgery. At any point
between the commissioning of a cranial plate and completion of man-
ufacture, a patient’s clinical need may change such that the originally
manufactured plate is no longer appropriate. This wastes both material
and prosthetist time, as shown in the ‘conventional’ branch of the
process diagram (Fig. 3).
In comparison, AM allows manufacture of cranial plates at a later
stage in the process chain. A digital model of the cranial plate can be
produced within hours by an experienced prosthetist, which can then
be viewed by surgeons and other clinicians the same day. This design is
archived and once a surgical date is conﬁrmed, manufacturing can
start, and a plate delivered for sterilisation within 2 weeks [64]. By
shifting to manufacture post-surgical scheduling, the likelihood of a
plate no longer being required is reduced, cutting waste. This alteration
of supply chains and introduction of lean manufacturing is similar to
the supply chain eﬀects observed in more general manufacturing set-
tings [65,66]. Crucially, plates manufactured using both fully and semi-
automated digital workﬂows show superior accuracy to conventional
hand-manufactured plates, reducing the need for adaption during sur-
gery [67]. Greater surgical duration has been associated with poorer
patient outcome [68], and whilst it is diﬃcult to unpick the association
between operative time, complications during surgery, and post-op-
erative complications, the importance of minimising surgical time and
related anaesthesia duration has been highlighted in several surgical
ﬁelds [69,70].
Despite the potential beneﬁts in both precision and eﬃciency, there
are however barriers to the widespread use and adoption of this digital
approach at national, regional, and hospital level. Across multiple UK
industries, provision of appropriate investment and training in the
Fig. 2. Examples of AM patient speciﬁc implants used for reconstruction of resected bone tumours and follow-up x-ray ﬁlms showing placement, speciﬁcally a)
clavicle, b) scapula, and c) uncemented proximal tibial reconstruction [52,53].
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application and use of AM has been identiﬁed as a common hurdle [71],
whilst studies of national healthcare providers across Europe have
shown uptake of novel technologies is highly dependent on hospital
funding at a regional level [72,73]. In a clinical setting, surgeons and
consultants unfamiliar with these new methods will be cautious to
adopt them until there is strong evidence for improved patient outcome
[74]. This may particularly be driven by required changes in surgical
technique. For example, plates produced by L-PBF require more precise
positioning due to a higher yield strength than conventional plates,
which can be manually deformed during surgery to ﬁt. This reduced
formability is in part due to the ﬁner grained metallurgical structure
and the higher thickness of L-PBF plates, reported as up to 3mm [75]
versus the sub-mm thickness of traditional pressed prosthetics [56]. To
overcome this reduced adaptability of the plate during surgery, custom
cutting or mounting guides can be provided [76], and whilst this in-
volves adjustments to surgical technique, in complex cases can reduce
surgical duration [49,77].
3. Future clinical beneﬁt
Currently, there is a large volume of research being generated at
every stage of the AM implant chain - from the materials produced by
the process, to the design of implants and the additional processes after
AM needed to produce a device suitable for implantation. Whilst there
are many steps before these innovations can be translated to clinic,
progress is being made against several of the core clinical challenges
faced. Immediate beneﬁts can be obtained through the greater ﬂex-
ibility of design enabled by AM. Opportunities are presented for new
design strategies at a mesoscale and macroscale, with focus given to
their use for osseointegration and reduced stress shielding respectively.
Implants with secondary clinical functions that could be manufactured
by PBF processes are also discussed. Further to this, the long-term de-
velopment of materials possible through AM is considered. With the
ability to rapidly prototype diﬀerent implant alloys by altering feed-
stock, geometrically complex samples of novel alloys can be produced
without the need for specialist casting facilities, and in small quantities.
Eﬀorts to produce alloys with low modulus and high strength are
considered, alongside the production of bioactive or resorbable alloys.
3.1. Design optimisation
AM allows manufacture of geometries previously considered un-
feasible, the most apparent example being reliable creation of designed
lattice structures. Taking advantage of this capability allows entirely
new implant features and functions to be created, meeting a range of
clinical challenges head-on. Particularly for load-bearing implants, en-
suring stability for long-term ﬁxation is a key clinical target. At a me-
soscale (at the interface between sub-millimetre microscopic scale, and
the macroscopic scale where an objects mechanical properties can be
reliably modelled with continuum mechanics), tailoring porous struc-
tures to encourage osseointegration is discussed, including an overview
of the relevant studies using AM materials. Moving beyond to macro-
scale design of implants, strategies for minimising stress shielding using
lattices are assessed. Using the ﬂexibility of AM to enable novel implant
functions is also discussed, with an emphasis on incorporation of a
second functional component or material.
3.1.1. Mesoscale design for osseointegration
The high resolution of powder bed processes enables design of im-
plant behaviour at the mesoscopic manufacturing scale – considered as
between microscopic sub-millimetre and macroscopic scales – with
production of lattice structures a clear example. Porous structures are
diﬃcult to produce through conventional implant manufacturing
techniques, having required production by powder metallurgy routes
[78], and with little regularity or control of the resulting pore structure.
Additive manufacturing allows for creation of controlled or ‘engineered’
porosity, potentially enabling direct osseointegration [17] whilst si-
multaneously reducing the eﬀective bulk stiﬀness of material or im-
plants [79]. Enhancing osseointegration is a key area of study to ensure
implant stability, particularly given the increase usage of cementless
hips versus cemented since 2003 in the UK [1]. Despite continuing
improvements in design, cementless implantation continues to be as-
sociated with a higher revision rate from 1 to 10 years compared with
cemented and it has been hypothesised that enhanced osseointegration
may improve medium to long-term outcomes [1,18].
Relevant pore characteristics and their eﬀect on osseointegration
have been studied extensively in AM materials, highlights of which can
be found in Table 2. An optimum minimum pore size is frequently cited
as 100 μm based on early studies of the phenomenon in ceramics [80],
with a maximum pore width below 1000 μm [81], and subsequent
studies in porous metal substrates have focussed on this regime. Studies
that have maintained a ﬁxed pore size, indicate that greater ingrowth
occurs at higher total porosity [82], whilst pore shape has not been
found to inﬂuence osseointegration directly but may direct cell growth
and diﬀerentiation in vitro [83,84].
Whilst an ideal pore structure has yet to be evidenced, in vivo
Fig. 3. Schematic of the processes-ﬂow to manufacture a custom Ti cranioplasty by conventional, manual means versus by a digital, additive manufacturing process.
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research has demonstrated improved osseointegration of porous me-
tallic implants compared to conventional materials. Multiple studies of
porous Ti lumbar fusion cages in an ovine model have demonstrated
signiﬁcantly higher osseointegration than both conventional polymer,
and titanium coated polymer alternatives [90,91]. Several manu-
facturers now utilise AM in the production of spinal fusion implants, as
identiﬁed in Table 1, both in Ti and CoCr based alloys. Whilst the
greater osteoconductive properties of Ti alloys over CoCr are well es-
tablished [92], both materials have shown long-term osseointegration
in lattice structures. Similar patterns of bone formation have been de-
monstrated for both Ti-6Al-4 V and CoCr in an ovine femoral model,
with higher surface contact between bone and Ti shown but a greater
osteocyte density at the periphery of the CoCr network indicating a
slower remodelling process [93]. The opportunity to improve osseoin-
tegration and reduce the stiﬀness of CoCr alloys is particularly im-
portant, given the higher stiﬀness and resulting tendency for stress-
shielding.
To support the development of these engineered porous structures,
osseointegration and relevant characteristics must be modelled in large
defects, including for lattices with deliberate variation in pore proper-
ties. Considering behaviour across pore structures may prove key to
maximising integration. Flow behaviour when seeding onto AM gra-
dient pore structures has been shown to be crucial, with gradually re-
ducing cell density and actin expression as pore size decreases deeper
into a gradient lattice [94]. Experimentally validated modelling tools
have indicated that both the pore size and surface roughness at a mi-
cron scale control ﬂow, and may be used to tailor it [95].
3.1.2. Macroscale implant design for stress shielding
For a given set of design constraints, such as volume and mechanical
function (referred to as a ‘design space’), AM enables far greater
freedom than conventional manufacturing techniques. In particular,
this allows for optimisation of the stress distribution within an implant
and its eﬀect on the defect site, reducing stress shielding and interfacial
motion at the bone interface, minimising the risk of aseptic loosening
[96].
Topological optimisation has been widely explored as an approach
to redesigning parts for AM to make use of this design freedom, within a
given design space. Typically such techniques are free to attain any
shape within loading constraints, however within a biomedical context
it is key to consider the anatomical site, and resulting overall shape of
an implant as a constraint [97]. Optimisation methods often rely upon a
theoretical variation of material behaviour within this envelope for
modelling purposes, for example reducing the local density of material
where appropriate to reduce stiﬀness [98], or varying material com-
position [99]. Gradients of composition within PBF techniques are not
possible [100], so in practice this variation of material behaviour across
an implant - commonly referred to as a functionally graded material
[101] - can be most easily achieved by the use of varying porosity and
lattice structures [102]. The principles of applying topological optimi-
sation and functional grading to implants using lattices, and the AM
speciﬁc manufacturing challenges involved, are discussed in depth by
Wang et al [103]. Suﬃce to say, it is key to include speciﬁc manu-
facturing constraints such as minimum feature size and the angle at
which material can ‘self-support’ within any topological optimisation
algorithm.
Reduced stress shielding achieved through functionally graded lat-
tices has been modelled in several key clinical contexts, including hip
arthroplasty femoral stems [104,105], and knee arthroplasty tibial
components [106]. Given that the loading of such implants lies pri-
marily along the stem axis, in vitro models have focussed on radial
grading of lattices [107]. Stem models featuring both closed outer
surfaces [108], and open radial grading with high porosity at the ex-
tremities to transfer stress to surrounding tissue [109], have been
manufactured and mechanically assessed to show improved stress dis-
tributions in comparison to solid stems. However, relatively few full-Ta
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implant models have been manufactured to demonstrate improved
stress distribution in practise. Initial in vitro testing in a femur model
has shown promise, potentially reducing secondary bone loss through
stress shielding by 75% compared to an equivalent solid implant 105].
Physical modelling and iteration remains necessary to optimise re-
sponse even for comparatively simple structures, as use of a porous core
without lattice grading shows signiﬁcant reduction in ﬂexural stiﬀness
beyond that predicted by computational modelling [110]. The me-
chanical behaviour of complex graded lattice structures is not easily
modelled outside the elastic deformation regime, making it diﬃcult to
accurately predict failure behaviour beyond bulk or global deforma-
tions. In order to better understand lattice failure, simple linearly
graded structures have been widely studied in vitro [111,112]. Under
compression, sequential collapse of layers prior to full densiﬁcation of
structures has been observed in graded lattices, both with linear and
curved gradients in density, with no signiﬁcant diﬀerence in the me-
chanical response to static and dynamic compression testing [113,114].
The degree of densiﬁcation between layer failures can be modiﬁed, as
demonstrated by structures using sigmoidal density gradients [115].
This may reduce the risk of a catastrophic collapse of multiple layers of
a lattice.
Lattice designs face challenges when applied to implant geometries,
particularly at the edge of the implant where unit cells will not natu-
rally terminate. Simplistic trimming of unit cells at edges with no
change in geometry potentially leaves unprintable or mechanically
unstable structures. Four key approaches to this challenge are re-
presented in Fig. 4, each of which has clinically relevant impacts on
behaviour of a structure. The addition of an outer ‘skin’ to support edge
cells has been proposed, with the additional stiﬀness producing a form
of functional grading (Fig. 4b) [107]. In certain clinical contexts, the
resulting retardation of osseointegration may be considered positive,
particularly if revision of the implant is considered likely [106]. Where
it is desirable to maintain an open lattice for osseointegration, net-
based skins may provide mechanical support without signiﬁcantly re-
ducing access to the lattice for post processing [116], though these
designs are computationally more complex to produce (Fig. 4c). Al-
ternatively, several computational methods have been proposed to
counter edge eﬀects by deforming lattice cells to conform to the desired
geometry. In the ‘swept’ method, the whole unit cell structure is de-
formed, however this only works for simple edges and can signiﬁcantly
alter mechanical behaviour (Fig. 4d). Use of a meshed method alters
unit cells in shape and size with ﬁnite element analysis to preserve
mechanical properties, but again sacriﬁces the original unit cell geo-
metry (Fig. 4e) [117].
3.1.3. Functional implants
Beyond the properties of a metal implant itself, AM can be used as
an enabler for other technologies, such as localised delivery of ther-
apeutic agents. Given that infection and aseptic loosening account for
over 40% of hip revision surgeries recorded over a 16 year period [18],
the ability of an implant to elute antimicrobials or osseointegration-
related factors is worth exploring. Coatings are well established as ef-
fective for both antimicrobial [118], osseointegrative properties
[119,120], but may be limited in duration of therapeutic eﬃcacy and
durability both prior and post implantation.
One example of an alternate AM-enabled approach to the delivery of
therapeutic agents is to consider the delivery vehicle as a distinct
second phase integral to the implant (Fig. 5). Intercalation of an eluting
phase within a lattice structure may be a way to combine stress
matching, therapeutic eﬀects, and improved osseointegration in one
implant [121]. This basic proof of concept has been established in cp-Ti
with a range of biocompatible ﬁllers [122]. Inﬁltration of a simvastatin
loaded hydrogel into a Ti-6Al-4 V scaﬀold showed signiﬁcantly greater
vascularisation, osseointegration, and bone ingrowth in a rabbit model
compared to equivalent structures without a secondary phase [123].
Alternatively, a larger and more controlled volume of material may be
delivered by integrating the second phase inside a physical reservoir,
i.e. a hollow implant. In this way, the release characteristics of the
therapeutic agents can be tailored both by altering the characteristics of
the delivery vehicle, and by modiﬁcation of the implant pore structures
through which elution is achieved [124,125]. Addition of permeable
membranes on the outside of a porous implant could further optimise
elution, and enable loading of the eluting agent prior to implant in-
sertion [126].
The ability to more easily generate hollow or porous structures may
also enable the deployment of integrated sensors. Advances in im-
plantable sensors have as yet been driven primarily by glucose monitors
or cardiovascular implants [127,128]. Whilst there are challenges in
preventing fouling of sensors and retaining analytical accuracy [129], a
range of advances have been made that make long-term implantable
sensors more viable as discussed by Vaddiraju et al [130]. Where im-
planted orthopaedic sensors have been demonstrated, mechanical load
data has been measured, which does not require contact between the
sensor and native tissue, preventing biofouling by encapsulation of the
device within the femoral neck. Potentially serious deﬁciencies in ex-
isting mechanical testing regimes for hips were established by mea-
surement of contact forces and moments within a hip implant, mea-
suring in vivo forces with greater magnitude and varying orientation
compared to ISO standards [131]. Moving towards in-situ measurement
of key post-operative markers for inﬂammation may provide greater
resolution than blood measurements, further building on improvements
in identifying peri-prosthetic infection [132].
3.2. Alloy development
Implanted biomedical alloy choice is restricted, with a narrow range
of Co-Cr alloys and Ti alloys dominating. Novel alloys have been ex-
plored by a range of manufacturing methods [133], but development is
Fig. 4. Methods for adapting a) a simple lattice structure, to prevent hanging edges. From left to right: b) solid skin encasing the entire lattice, c) net skin joining key
lattice segments, d) swept.
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typically time consuming and requires specialised equipment, with
diﬃculties in creating complex geometries limiting the use of materials
such as NiTi [134]. Due to the powder feedstock that PBF processes are
reliant upon, it is possible to create and validate entirely new alloys
either by pre-alloying during atomisation of powders, or simply by
blending of feedstocks. A range of compositions can be rapidly assessed
at lower expense, by mixing elemental or alloyed powders such that
localised homogenisation of the alloy occurs during the AM process
[135]. Two broad subsets of alloy are considered; those with low
modulus to minimise stress shielding, and ‘bioactive’ alloys that emit
therapeutic materials or are resorbed with time. Validating a broader
range of materials will increase design ﬂexibility, and enable selection
of materials to be better informed by clinical need and not only avail-
ability. Note however, that development of new materials should be
considered a long-term goal given the complexity of validating alloys as
safe for biomedical use, particularly when implanted for extended
periods of time.
3.2.1. Low Modulus alloys
One approach to reducing the stress-shielding problem has been the
development and testing of novel, low-stiﬀness alloys [133]. Finite
element modelling of these materials versus conventional alloys has
shown signiﬁcantly lower ‘stress-jump’ at the implant-bone interface
[136], which in turn will reduce stress-shielding and is one motivator
for their use. Particular focus has been dedicated to metastable beta
phase titanium alloys due to the high biocompatibility of Ti. A new
series of such alloys have been produced by AM, and the elastic mod-
ulus and tensile yield strength of these materials is shown compared to
Ti-6Al-4 V and cp-Ti (Fig. 6). Note that though yield strength is reduced
in comparison to Ti-6Al-4 V, signiﬁcantly lower elastic moduli are
achieved whilst retaining strength above that of cp-Ti. In most cases,
these alloys have used a modiﬁcation of previously developed TZNT
(Ti-Zr-Nb-Ta) and TMZF (Ti-Mo-Zr-Fe) systems, whose biocompatibility
is well established. These developments have not been limited to solid
components; multiple authors have reported the fabrication of im-
plantable scaﬀolds from low modulus alloys [137–140]. The use of
lattice or scaﬀold structures, enables further optimisation of mechanical
response including reducing the eﬀective stiﬀness of an implant, as
discussed in Section 3.1.2. Whilst these results are signiﬁcant for ap-
proaching the modulus of healthy bone, it is worth noting that the low
eﬀective modulus can be induced by unintentional or process induced
porosity [79,141], which could prove problematic for fatigue strength.
The tribological behaviour of these newly developed alloys has yet
to be investigated, which may prove a signiﬁcant barrier to use. For
example, though the TMZF system was commercialised for modular
femoral stems by Stryker, they were recalled in the United States by the
Food & Drug Administration (FDA) in 2011 due to excessive wear de-
gradation [153]. The anomalous behaviour has been linked to the low
strain hardening behaviour of the alloy, which is intrinsically linked
with its beta-phase nature [154]. Similar low strain-hardening beha-
viour has been reported by researchers focused on the development of
other beta-phase alloys [146,147], typically in reference to the addi-
tional ductility gained as a result. Whilst greater elongation to failure
can be beneﬁcial, consideration should be given to its eﬀect on wear
degradation and whether such a material will be viable in wear-critical
applications (e.g. joint articulating surfaces).
Parallel to development of beta-phase Ti alloys through in-situ al-
loying, considerable progress has been made in manufacturing alloys
where complex geometries are impractical by traditional means, such
as NiTi [155] and bulk metallic glasses (BMGs). The amorphous
structure of BMGs, which enables low stiﬀness with up to 50% higher
yield strength than Ti-6Al-4 V, has been linked to high biocompatibility
[156]. Given the reduced yield strength seen in beta phase Ti alloys, the
enhanced strength of BMGs is appealing. A range of diﬀerent BMG
compositions have been demonstrated in L-PBF, including Ti-based
[151], Fe based [157], and multiple Zr based alloys [148,149]. Further
to this, the addition of an amorphous glass fraction to a conventional
alloy has been shown using 316 L stainless steel and a Fe based BMG
[158]. This composite showed improved corrosion resistance, strength
and reduced friction versus 316 L alone. Critically for clinical
Fig. 5. Schematic visualising three approaches to adding therapeutic materials to an implant to achieve additional functionality; conventional addition of a coating,
intercalation with an AM lattice structure, and inclusion of an internal reservoir through AM.
Fig. 6. Graph showing the tensile properties of additively manufactured low-
modulus alloys in comparison to conventionally and additively manufactured
Ti-6Al-4 V and cp-Ti, and the elastic moduli of cortical bone. Reduction in
stiﬀness correlates with a reduced yield strength for beta phase titanium alloys
compared to Ti-6Al-4 V, whilst metallic glasses show enhanced strength
[141–152].
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application, the use of AM unlocks greater geometric complexity than
can be achieved in other BMG manufacturing methods [159]. Highly
complex structures with sub-mm features have been produced (Fig. 7),
demonstrating glassy-lattice structures and suﬃcient precision to ac-
curately replicate healthy bone geometry.
Although BMGs may have a high impact in biomedical applications,
there remain signiﬁcant barriers to their clinical application in the near
term (whether manufactured by AM or otherwise). Diﬃculty in control
of porosity, and the trade-oﬀ between costly noble metals such as Pd
and potentially cytotoxic elements for example Ni and Be, all need to be
overcome before translation to in vivo models [156].
3.2.2. Bioactive alloys
Investigations have been made into alloys that, rather than being
eﬀectively inert in vivo, exhibit actively osteogenic or antibacterial
properties [160]. Particular focus has been on addition of antimicrobial
metal ions, such as silver or copper, but experimental materials with
integrated hydroxyapatite (HA) have also been demonstrated (Table 3).
Note that none of these materials have yet been tested in vivo nor, to the
best of our knowledge, have any HA containing materials been tested
with mammalian tissue cultures.
Considerable characterisation is needed to ﬁnd the optimum
thermal processing during additive manufacture or heat treatment post-
processing, as investigations in non-AM produced antimicrobial alloys
have suggested speciﬁc metallurgical phases dominate release kinetics
[179]. Alongside this, further studies are required to establish the op-
timum loading of therapeutic materials in alloys. Particularly for those
alloys that directly incorporate HA, the eﬀect of incorporating addi-
tional elements can signiﬁcantly alter corrosion behaviour, and may
override any beneﬁts from improved antimicrobial behaviour or
osseointegration. Given the clear mechanical degradation addition of
HA has on composite alloys, a more subtle microalloying approach may
prove more mechanically viable in the long-term. Inclusion of key al-
loying elements to feedstock, such as zirconium to CoCr alloys, has been
explored. Using a rabbit femoral model, Zr additions as low as 0.04 wt%
increased the torque required to remove implants after eight weeks by
10% [180]. Further histological study of implants in rabbit femur sites
showed similar mineral crystallinity, apatite to collagen ratio, and os-
teocyte density to equivalent CoCr implants after eight weeks [181].
Rather than simply encouraging osseointegration, one radical ap-
proach to negate mechanical mismatch in vivo is the use of bioresorb-
able Mg, Zn, or Fe alloys, which can be gradually absorbed and replaced
by new bone tissue. Clinical trials have shown promising results for the
use of Mg in cardiovascular and bone ﬁxation applications, but mana-
ging the resorption rate of larger implants is still an open issue
[182–185]. Notably, excessive levels of elements considered ‘bio-
compatible’ can lead to severe side eﬀects, such as the production of
gaseous pockets in the case of Mg [186,187]. Moreover, changes in
geometry of implants as they resorb must be tailored to retain load-
bearing requirements. Additively manufactured porous structures may
oﬀer a new way to optimise uniformity of degradation, enabling mass
transport and allow resorption throughout the volume of an implant
(Fig. 8), a concept investigated sporadically using non-AM methods
[188]. The ability to control pore structure via L-PBF has promoted the
production of a considerable range of resorbable scaﬀolds [189,190].
The eﬀect of porosity on the degradation rate of the Mg alloy WE43 has
been demonstrated in depth, with resorption occurring across the entire
scaﬀold and retention of adequate strength and stiﬀness for 4-weeks in
vitro 190]. In an eﬀort to further optimise degradation kinetics, the use
of a polycaprolactone (PCL) coating has been investigated in a mouse
Fig. 7. Bulk metallic glass structures fabricated by L-PBF in a) Zr52.5Cu17.9Ni14.6Al10Ti5 and b) Ti47Cu38Zr7.5Fe2.5Sn2Si1Ag2 [149,151].
Table 3
Examples of additively manufactured bioactive alloys, showing the wide range of base systems and fraction of therapeutic material included.
Active Agent Base Alloy Fraction (wt%) Key Findings Source
Hydroxy-apatite (HA) 316 L steel 5 - 15 vol% Across all alloys, observe signiﬁcant reductions in tensile strength and fracture toughness. Associated
with porosity and dissolution of P into base alloys.
[161]
[162]
cpTi 2.0 - 5.0 [163]
0 - 5.0 gradient [164]HA acts as a grain reﬁner, increasing hardness. Increases stiﬀness in Ti.
Ti-6Al-7Nb 5.0 In Mg-3Zn, see reduced corrosion rate due to protective apatite formation - may also be due to grain
reﬁnement.
[165]
NiTi 25 [166]
Mg-3Zn 2.5 - 10 [167]
Cu 316 L 4.5 Antimicrobial behaviour increased with aging of alloy, at the cost of lower corrosion resistance. [168]
2.5 - 3.5 [169]Cytocompatibility demonstrated.
Ti-6Al-4V 1.38 Eﬃcacy versus E coli and S aureus demonstrated. Observed increase in strength and reduced ductility. [170] [135]
5.0 [171]Cytocompatibility demonstrated. Addition of Cu encourages diﬀerentiation of osteoblasts.
2.0 - 6.0 [172] [173]
Co-29Cr-9W 3.0 Antimicrobial eﬃcacy demonstrated against E coli and S aureus. Cu increases resistance to corrosion
and wear. Cytocompatibility shown.
[174,175,176]
ZK60 Mg
alloy
0.2 - 0.8 Increased strength, strong antibacterial and cytocompatible. [177]
Ag Ti-6Al-4V 0.5 Dramatically increases ductility, but shows minimal antibacterial behaviour at this level. [171]
ZK30 Mg
alloy
0.25 - 1.0 Increased hardness and compressive strength, reduced degradation rate and increased eﬃcacy against
E. Coli versus ZK30 alone.
[178]
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calvarial defect model, however the rate of resorption remained suﬃ-
ciently high that voids were observed between the implant surface and
mineralised bone after 84 days [191].
Magnesium alloys have been the most widely used resorbable alloys
[192,193], and as a result a wide range have been processed by L-PBF,
including pure Mg, WE43, AZ91 and several Mg-Zn alloys
[167,189,190,194–200]. When produced by conventional means, Mg
alloys and particularly pure Mg show low tensile strength, of the order
of 30MPa when cast, requiring heat treatment as a result [192]. This
may be countered by the ﬁne-grained microstructure AM processes
typically produce, whilst concurrently decreasing degradation rate
[201], as has been shown in AZ61 alloy [199]. Initial indications of
higher micro-hardness of pure Mg versus as-cast are promising in this
regard 194]. Processing of Mg by L-PBF does nonetheless present
challenges, the foremost being the narrow temperature range between
melting and boiling points that risks evaporation of material in-process
[196,202]. Similar restrictions in Zn have been managed with in-situ
monitoring of melt behaviour [203].
Although no human trials have been carried out on Zn or Fe based
degradable implants, they remain a valid option for bioabsorbable
implants [187]. The ability to process both of these materials has been
demonstrated in L-PBF [204], with densities in excess of 99% achiev-
able in Zn [205,206]. Unlike Mg alloys, Fe based alloys often feature
excessively slow degradation due to passivation, a problem that has
been combated in L-PBF by addition of silver to optimise corrosion
properties [207]. However, concerns of biocompatibility remain, with
40 times lower daily exposure observed under normal circumstances in
comparison to Mg [187]. Excess Zn may hinder bone development and
at extreme levels causes neurotoxicity, whilst Fe may produce gastro-
intestinal lesions and liver damage. Further investigation of the alloying
content in many Mg alloys is also required, as the toxicity of Yttrium
and other rare earth elements found in WE43 alloy is still not well
understood [208].
4. Challenges of additive manufacturing
Whilst there are potential clinical and economic gains to be made
from wider use of AM, there are a range of challenges to the reliable
manufacture of implants on a mass scale for load-bearing applications.
Diﬃculties can arise both in the initial processing of material, and in
the subsequent post-processing of manufactured implants required to
achieve optimum mechanical properties.
4.1. Material processing
As with any manufacturing process, AM processes exhibit unique
defects that can be detrimental to mechanical behaviour, and require
careful optimisation to avoid. As previously discussed, additively
manufactured materials show inherently diﬀerent microstructural and
mechanical behaviours compared to conventional wrought or cast
material. High heating and cooling rates result in ﬁne microstructures,
whilst the layer-by-layer nature of PBF generates anisotropy and het-
erogeneous mechanical response. This behaviour is highly process de-
pendent, with a wide range of variables that can be tailored.
Defect generation and techniques for prevention are considered,
with a focus on in-process optimisation. Signiﬁcant work may be re-
quired to optimise mechanical properties to meet or exceed those of
conventional materials, including the removal of anisotropy. However,
consideration is given to possible functionalisation of material by in-
duced localised anisotropy.
4.1.1. Defect prevention and fatigue behaviour
One of the greatest barriers to wider orthopaedic adoption of AM is
a general concern regarding the formation of defects during processing,
and particularly their eﬀect on the fatigue strength of AM materials. It
has been widely demonstrated that the ﬁner microstructures produced
by EB-PBF and L-PBF oﬀer comparable or increased tensile strength to
conventionally manufactured equivalents [209]. However, studies have
shown reduced fatigue strength in an as-manufactured state compared
to cast or wrought materials in multiple orthopaedic alloys [210,211].
This is typically ascribed to the high residual stresses in as-manu-
factured samples, and to a range of process defects as described in
Table 4 [212].
Whilst internal defects may be closed after manufacture by use of
hot isostatic pressing (HIPing) [211], so far as reasonably practicable
the ﬁrst recourse should be prevention of defect formation, followed by
improvement of post-processing and thermomechanical treatment.
Comparisons of Ti-6Al-4 V made using diﬀerent machines and proces-
sing parameters has shown that machine-to-machine variability is a
signiﬁcant factor in determining fatigue lifetime [213]. Regardless of
their eﬀect on fatigue, formation of defects indicates a lack of process
control that may draw concern from regulators. Complementary ad-
vances concerning in-situ process monitoring and metrological inspec-
tion methods could translate to improved process reproducibility and
stability [214]. In-situ monitoring modules are now available from
several key machine manufacturers, that validate the uniformity of
Fig. 8. Schematic showing loading of a resorbable implant under compression, and the resulting change in stress proﬁle of surrounding bone as material resorbs. In a
solid implant, the central section of bone continues to suﬀer from stress shielding, whilst in principle a lattice structure evenly distributes mass loss and load.
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powder bed or melt pool characteristics, though data on the improve-
ment in process quality achieved are limited [215–218].
Alongside physical modules for optimisation, manufacturers typi-
cally provide ‘default’ parameters with which to produce material –
however, signiﬁcant further optimisation is possible. Starting from the
default supplier parameters for Ti-6Al-4 V, parametric optimisation has
reduced porosity in EB-PBF approximately threefold, with remaining
pores ascribed to entrapped gas in feedstock [219]. The cause and
morphology of porosity should be considered as well as total volume
fraction. In some cases, a trade-oﬀ may be made between types of de-
fect, with spherical pores from overmelting in L-PBF as shown by
Table 4, considered favourable to elongated voids along build layers
[220].
A frequently overlooked aspect of process optimisation for AM is the
selection and validation of feedstocks. The majority of materials for
powder AM processes are atomised, which can lead to entrapment of
gas within powder particles [221]. Gas atomised powders often show a
greater degree of entrapment than those produced using plasma ato-
misation, with this risk being balanced against a lower cost to manu-
facture [39]. A frequent argument for the use of more costly plasma
atomised or spheroidised powders is the improved ﬂow properties in-
herent to a more spherical morphology [40]. However, with appro-
priate consideration, rough and non-spherical powders have been
shown to be processible in EB-PBF [222], and the degree of remnant gas
entrapment can be reduced by altering scan strategy to enable gas re-
lease [223]. Independent assessment of powder quality should be
considered prior to manufacture, including feedstock that is being
recycled or reused. Repeated re-use of powders through PBF processes
can be tolerated, though it is common to observe an increase in oxygen
content with recycling. Whilst this may reduce ductility, it has been
shown that even CoCr powder subjected to deliberate oxidation still
produced material within the required standard for cast F75 alloy
[224].
4.1.2. Heterogeneous microstructures
Microstructural heterogeneity and bulk anisotropy are established
characteristics of additively manufactured parts. Extreme heating,
combined with the layer-wise nature of manufacture, frequently results
in elongated grain structures that are heavily dependent on local
cooling conditions with typical rates in excess of 104 Ks−1 [28]], [227].
Epitaxial growth of such grains parallel to the build direction is a fre-
quent issue in both laser and electron beam techniques due to remelting
of previously deposited material [228]. Such uncontrolled anisotropy
causes variation in both tensile and fatigue strength, which must be
well understood for any load-bearing application [229,230].
The degree of heterogeneity is highly dependent on process control.
Laser power has been shown to have little eﬀect on microstructure scale
in L-PBF produced Co-Cr-Mo alloy [231], while laser path behaviour
altered both dominant crystallographic orientation and extent of co-
lumnar grain growth [232]. The behaviour of speciﬁc phases must also
be considered, as investigated in the role of carbide precipitation in-
duced anisotropy in Co-Cr-Mo produced by EB-PBF [233]. There are
continuing eﬀorts to optimise process parameters to minimise micro-
structural heterogeneity, such as in-situ optimisation of Ti-6Al-4 V by
Table 4
Common internal defects observed in AM parts linked to reduced fatigue strength. Images with publisher’s permission from [225,226].
Defect Cause Typical Morphology Image
Pores Entrapped gas within feedstock powders from
atomisation process.
Spherical pores of similar size to feedstock particles.
Lack of fusion Incomplete melting of material in process. If
consistent across a layer, may lead to
delamination due to poor adhesion.
Entrapped unmelted powder feedstock, often in small
clusters with surrounding cracks or pores. Frequently
observed at fatigue crack surfaces.
Keyholing Excessive energy input during processing
causing localised vaporisation of material,
resulting in pore formation.
Aspherical pore, often surrounded by atypical
microstructure in V-shape parallel to build direction.
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altering process characteristics. Decreasing the time between melting
layers, and increasing layer thickness encourage equiaxed grain for-
mation as opposed to columnar grains, simultaneously increasing duc-
tility by promoting decomposition of martensite [234]. Improvements
in microstructure have also been shown through a novel approach using
a static magnetic ﬁeld during L-PBF of cp-Ti, reducing the degree of
texture observed [235]. However, subsequent heat treatment currently
remains the most eﬀective method for resolving microstructural var-
iation, adding a costly and time consuming processing step to achieve
ideal microstructure and performance [143].
Despite isotropy of materials being favourable under many cir-
cumstances, the material behaviour and stress states of load-bearing
bones are complex and anisotropic [236]. Cortical bone, for example,
exhibits Young’s moduli of 20.9 and 11 GPa in the tibia, parallel and
perpendicular to the long bone axes respectively [150]. Alongside
minimisation of anisotropy through optimisation of process control,
interest is growing in deliberately producing material inhomogeneity to
produce mechanically anisotropic materials [237]. The degree of
crystallographic anisotropy achievable in a Ni alloy, as shown in Fig. 9,
is high resulting in stiﬀness correlating with a basic rule-of-mixtures
model [238].
No functional grading has yet been demonstrated along the X–Y
plane of biomedical alloys within a single component. However, al-
ternating layers of microstructures have been produced in a NiTi shape
memory alloy, with alternate austenitic and martensitic structures in-
ducing the Elinvar eﬀect, where the temperature dependence of stiﬀ-
ness is negligible [240]. A similar high degree of microstructural con-
trol has been demonstrated over low modulus Ti-15Mo-5Zr-3Al alloy,
preferentially generating either< 001> and<011>orientations
along the build direction [239].
4.2. Post-process optimisation
Whilst the ease of access to AM technologies continues to increase, it
remains the case that metal powder technologies are far from a ‘press-
play’ solution. The surface ﬁnish and mechanical properties of parts in
the ‘as-built’ state can be signiﬁcantly improved upon with appropriate
post manufacture processing. The application of conventional surface
ﬁnishing techniques to AM implants is non-trivial for several reasons;
1 Novel implant geometries, including porous scaﬀold or lattice type
structures, which preclude the use of many line-of-sight techniques.
2 Speciﬁc initial surface ﬁnish of AM implants, including partially
adhered powder feedstock and variable roughness with orientation.
3 Possible needs for variable ﬁnish across implants (e.g. roughened
outer surface of acetabular cups for osseointegration vs polished
interior articulating face).
These same complications may clash with existing coating techni-
ques such as plasma spraying or sputtering, which are frequently used
to add functionality, particularly in orthopaedics.
Alongside surface ﬁnishing, thermal processing is a key considera-
tion to optimise microstructure and reduce the risk of fatigue induced
failure. As such in this section, the state of the art in both surface and
thermal processing is covered.
4.2.1. Surface processing
Conventional surface processing techniques used for biomedical
implants face severe challenges when applied to AM structures. For
example, sand-blasting followed by acid etching (SLA - Sand-blasted,
Large grit, Acid etched) is a common surface ﬁnishing technique used to
induce multi-scale roughness, both on commercial implants and in a
laboratory setting [241,242]. However, its high directionality makes it
inappropriate for the ﬁnishing of complex geometries or lattices [243],
and the existing roughness of as-built AM surfaces may encourage en-
trapment of remnant grit, with a detrimental eﬀect on biocompatibility
and increased risk of bacterial colonisation [244]. Several commercially
available implants utilise designed porosity, such as acetabular cups,
and whilst bearing surfaces are machined smooth, removal of remnant
powder from the porous surface is a key consideration. Ultrasonic
cleaning is often raised as an option, however may be insuﬃcient to
remove all remnant particulate matter [245], and will do little to re-
move surface defects common to AM parts that reduce fatigue strength
[246].
To cope with complex geometry, liquid-phase techniques oﬀer a
way to access all exposed surfaces. In non-medical ﬁelds, interest has
focussed on use of abrasive ﬂow machining (AFM) and its derivatives,
in which a suspension of abrasive media is forced through a vessel
containing the specimen to be polished. The viability of hybrid che-
mical-abrasive ﬂow techniques for internal channels has been veriﬁed
for additively manufactured specimens [247], whilst ultrasonic cavi-
tation abrasive ﬁnishing (UCAF) also showed promise using a range of
Fig. 9. Electron backscatter diﬀraction (EBSD)
analysis showing the extent of crystalline ani-
sotropy achievable using diﬀerent laser scan-
ning parameters during L-PBF. The index map
shown at top right applies to both a) a transi-
tion between ﬁne, randomly oriented grains
and coarse, aligned grains in Inconel-718 by
altering power, and b) tailoring of grain or-
ientation in a Ti alloy by changing the scan
direction (SD) of alternating layers. [238,239].
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abrasive concentrations, including cavitation with no abrasive [248].
Translation of these technologies to a medical ﬁeld would require
careful consideration of toxicity of the etchants or abrasives used while
still considering the risk of remnant media.
In order to avoid any form of remnant media, various chemical
polishing processes - referred to in terms of etching or passivation de-
pending on the eﬀect on surface oxide state - have been used on bulk
and lattice structures. A mixed acid polish using nitric and hydroﬂuoric
acids removed a signiﬁcant proportion of adhered powder from the L-
PBF process [249], and also reduced S. Aureus bioﬁlm formation on Ti-
6Al-7Nb lattices compared to ultrasonic cleaning alone [139]. From an
osseointegrative perspective, alkaline etching of commercially pure Ti
with a mix of NH4OH/H2O2 boosted proliferation of MG-63 cells [250].
However, such chemically aggressive processes may have negative ef-
fects on a part’s strength, with signiﬁcant mass loss in lattice structures
due to the high surface to volume ratio (Fig. 10). Excess material re-
moval can signiﬁcantly reduce fatigue strength as demonstrated in
Acid-Alkali treatments of Ti-6Al-4 V [251], negating the beneﬁts typi-
cally seen from removing surface defects or remnant media [252]. Al-
lowances for the reduction in volume must be included at a design stage
to compensate once appropriate analysis of mass and volume loss has
been made, as has been demonstrated for existing liquid phase tech-
niques, such as electropolishing [253].
As well as modifying roughness, these processes may alter the
chemical composition of the surface, through deposition of remnant
abrasive [244], or modiﬁcation of oxide layers [251]. It is important to
consider the eﬀect of any post processing on oxide behaviour, as the
extent and morphology of oxide ﬁlm growth can be controlled [254].
Notably, both thickness [255] and microstructure of the oxide layer can
alter cell response [256].
A ﬁnal aspect of surface processing to consider is the well-estab-
lished use of coatings to generate combination products capable of
delivering therapeutic agents [257–261]. The fundamental principles of
these technologies are generally not expected to behave diﬀerently on
AM materials to conventionally manufactured implants due to nomin-
ally identical chemistries. However, there has been relatively little
consideration of how to adapt coatings for the complex scaﬀolds or
porous structures possible with L-PBF and EB-PBF. As with surface
ﬁnishing, liquid or gas phase processes show the greatest promise to
adequately deal with such complex geometries, with Yavari et al de-
monstrating the doping of titanium scaﬀolds with silver ions for anti-
microbial eﬀect [262], and multiple papers reporting liquid-phase ap-
proaches to coat lattices with a range of hydroxyapatite derivatives
[263–266], silicates 266], and collagen [267]. On the other hand,
discussion of coverage quality achieved is rare. When investigated, poor
uniformity across the internal structures of lattices is noted, for example
in the integration of poly-ε-caprolactone and poly(3-hydroxybutyrate)
[191].
Given the challenges related to coating AM parts, even in liquid
phase, signiﬁcant further thought needs to be given to whether there
remains utility in line-of-sight techniques, such as plasma-spraying or
physical vapour deposition in combination with complex geometry
[268]. Moreover, it is worth a measure of caution in the use or reliance
upon novel coating technologies, as whilst there are a range of ortho-
paedic coatings approved for use, a large proportion of developed
surface coatings remain in a pre-clinical phase [261]. Though aligning
development of novel AM implants and related coatings may provide a
leap in theoretical clinical beneﬁt, critical assessment of the viability to
combine them is necessary.
4.2.2. Thermal post processing for fatigue
Whilst bulk defects should be minimised in-process, the inherent
limitations of AM processes necessitate a degree of post-processing to
obtain optimal fatigue performance. It is important to note that, pro-
vided appropriate process control and post-processing is applied, AM
materials do not inherently show poorer fatigue performance than
conventional materials. Comprehensive study of literature for AM Ti-
6Al-4 V by Li et al has shown that combining surface ﬁnishing and heat
treatment, fatigue performance even exceeds cast and wrought material
[269].
That being said, the as-built state of AM parts can be challenging,
with surface texture acting as nucleation sites for fatigue cracking
[270], whilst residual thermal stresses or sub-optimal microstructures
can reduce fatigue lifetimes [271]. Where possible, machining or pol-
ishing can dramatically increase fatigue lifetime by removal of surface
defects [272]. If internal defects occur, HIPing is currently the only
viable post-process technique to close defects. It is important to con-
sider the alloy speciﬁc requirements of any heat treatment, and there
have been extensive studies on the eﬀects of HIPing in Ti-6Al-4 V due to
its frequent use in non-biomedical contexts [212,273–276]. HIPing has
been shown to increase fatigue lifetime [275], but there is evidence that
it has negligible eﬀect on fatigue strength when variable amplitude
loading is considered 276]. This is crucial to orthopaedic settings, as
variable loading is typical during walking and is observed in ortho-
paedic models [277]. There are fewer studies of CoCr based alloys,
though similar improvements in fatigue strength from the as built state
Fig. 10. Reconstructions of micro X-ray computed tomography scans of a Ti-6Al-7Nb lattice structure a) before and b) after chemical etching with aqueous 6 vol% HF
and 14 vol% HNO3 for 600 s. Note the visible decrease in volume. [249].
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are observed following HIPing [211]. In all alloys, care must be taken
where pores are introduced by entrapped gas within atomised powder
feedstocks, as subsequent heat treatment may reopen pores initially
closed by HIPing [278].
Eﬀorts have been made to negate the need for post-process heat
treatment, particularly with respect to residual stresses induced by high
thermal gradients during processing. Careful optimisation of scanning
parameters can reduce thermal gradient, leading to, in one case, a re-
duction in thermal deformation of 36%, though this is signiﬁcantly less
than the 80% reduction achieved through heat treatment [279].
Maintaining an elevated chamber temperature during manufacture as
in EB-PBF and certain hot-bed L-PBF setups can provide some stress
relief [280–282], but heat treatment remains the most easily accessible
and optimal method for improving fatigue strength.
Further work is also necessary to develop models of fatigue beha-
viour for AM materials, particularly lattices which are especially prone
to fatigue, exhibiting lower normalised fatigue endurance limits than
solid material [283]. Multiscale techniques show promise by con-
sidering a microscale model at a crack tip, whilst simplifying to a
macroscopic model of stress distribution further from the tip [284], but
may be diﬃcult to apply to complex implant geometries. In practice, a
combination of etching to remove surface defects, and HIPing to
minimise internal defects and provide heat treatment, has been iden-
tiﬁed as an optimal method for improving Ti-6Al-4 V lattice fatigue
lifetimes, particularly in the high cycle regime [252]. Similar chemical
etching has also shown promise in CoCr F75 alloy, with performance
under quasi-static fatigue retained [285], though the eﬀect of thermal
processing requires further study.
5. Regulatory challenges
As with any new medical device, compliance with regulation to
ensure patient safety must be considered well in advance of submission
to regulatory bodies. Within the Europe Union, the ongoing transition
from the Medical Devices Directive (93/42/EEC) and Active
Implantable Medical Devices Directive (90/385/EEC) to the Medical
Devices Regulation (Regulation (EU) 2017/745) or ‘MDR’ has increased
both awareness and scrutiny of implantable devices [46]. As discussed
in Section 2, the current approach to implant manufacture can be
broadly segregated into two groups;
1 Patient-speciﬁc or “custom” devices where no alternative implant
exists, whose use can be justiﬁed through last resort where the
beneﬁts outweigh the risks of a novel device
2 More typical mass-manufactured implants that must be proven to
meet or exceed performance of existing devices
The need to prove equivalent performance to existing implants is
especially true in the case of ‘active’ implants, i.e. those with load
bearing and articulating behaviours as in orthopaedics. Whilst this is
not an unfamiliar regulatory barrier when considering new design
geometries, it is in proving equivalent performance of materials that
AM faces signiﬁcant barriers. Current materials used, such as cast or
wrought Ti-6Al-4 V, Co-Cr, or 316 L steel, are considered well-char-
acterised, with understood behaviours over periods of 10–15 years in
vivo. Materials produced by AM, regardless of equivalence of compo-
sition, are not yet at this stage of well-characterised behaviour, and as
discussed in Section 4.1.1, frequently show diﬀerent failure behaviour
[210]. As such, a signiﬁcant burden of proof will lie in proving either
direct equivalence of behaviour, or appropriate consideration and in-
vestigation to mitigate risk. Note also the extended period of behaviour
that must be considered, with the need to ‘identify and analyse the known
and foreseeable hazards associated with each device’ (MDR Annex I,
Chapter 1, 3(a).) [46]. Within the context of the MDR, demonstration of
equivalence to an implant also relies upon access to data generated
during validation of said implant. If this has been produced by another
manufacturer, unless the data generated has been published, accessing
such conﬁdential information may prove challenging to new manu-
facturers entering the market.
Considering the L-PBF or EB-PBF processes in more detail, control
and traceability of powder feedstocks is one example of the process-
speciﬁc challenges present. Manufacturers of feedstock will come under
increasing pressure to demonstrate provenance of the material entering
atomisers, guaranteeing only single alloys have been used and ensuring
the quality of resulting powders. Several large powder suppliers have
achieved ISO 13,485 to supply for medical applications, and proof of
compliance with this and future standards will remain critical as AM
production becomes more common [286,287]. Once obtained, feed-
stocks need to be appropriately validated, and whilst guiding standards
such as ASTM F3049-14 exist there is as yet no harmonised standard
suite of characterisation processes that should be applied as a
minimum, even if there are standards for individual tests [288]. Beyond
initial characterisation, the common practise of reusing or ‘recycling’
powder that has not been melted during the process will require justi-
ﬁcation, with validation that any shifts in size distribution and oxygen
content are acceptable [289,290]. The physical manufacturing process
must also be standardised for each approved device, and the exact
process parameters used justiﬁed to the notiﬁed body. Scanning and
melt parameters as well as tolerances, and acceptable deviations in part
dimensions are all aspects that should be considered. This presents an
opportunity for a leading supplier to establish a standard for others to
follow, as currently there are no harmonised standards relating to
process parameters, merely mechanical behaviour of produced mate-
rial.
The burden of proof lies with the manufacturer to prove the device
performs as well as or better than existing approved implants; above all,
every step of the manufacturing process from feedstock to sterilisation
must be appropriately considered, justiﬁed, and validated. Validation of
work conducted for the compilation of a pre-market technical dossier
must be conducted in line with current standards - particularly har-
monised EN ISO standards where possible - or if appropriate standards
do not exist, following engineering or scientiﬁc state of the art. Given
the broader push for standard development across the AM sector, it
remains in the interest of medical device manufacturers to be involved
in this process and drive standards in a useful direction.
6. Conclusions
Across researchers, manufacturers, regulators, and clinicians, AM
presents opportunities for new approaches. Though data for long-term
outcomes remain limited, additive manufacturing of metallic implants
has shown clear beneﬁts in application to patient speciﬁc implants.
Assessing a case study of cranioplasty manufacture, the additional de-
sign ﬂexibility oﬀered and greater feedback possible between clinicians
and prosthetists provides a model for broader adoption.
There are a number of advances being made in laboratory settings
that show promise for translation, which have been discussed with
speciﬁc clinical targets in mind. The added ﬂexibility of design and
material possible through AM show particular promise to reduce stress
shielding, a major factor in revisions due to aseptic loosening. With that
in mind, it is critical for researchers to consider the viability of bringing
such advances into clinical practice. Several challenges remain to
widening the use of AM implants, particularly in guaranteeing the
consistency of material produced and its optimum performance.
It is crucial that the full path to translation is considered during
research, including the long-term goal of clinical use. Considering the
current regulatory framework for implantable devices, there are chal-
lenges to meeting the high speciﬁcation needed for orthopaedic appli-
cation. Equally, as AM becomes more widely used, it may be necessary
to reassess the regulatory position on the breadth of 'design envelope'
that covers mass manufactured implants.
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